Southall E, Nutt N R, Thomas R D
J Int Med Res. 1982;10(5):361-6. doi: 10.1177/030006058201000509.
The effect of verapamil 120 mg t.d.s. was compared with propranolol 160 mg b.d. in the treatment of stable angina pectoris. Nineteen patients were studied in a randomized, double-blind, crossover trial, using patient diaries, exercise-testing and ambulatory electrocardiographic monitoring. Both drugs were given for 1 month. On average the number of attacks of angina was reduced equally by verapamil and propranolol. The degree of electrocardiographic evidence of myocardial ischaemia was decreased by the same amount, but verapamil was significantly more effective in prolonging the exercise time. Both drugs reduced the number of episodes of ST-segment depression during 24 hours of ambulatory electrocardiographic monitoring, which was analyzed in nine patients. It is concluded that verapamil compares very favourably with propranolol in the treatment of stable angina, and is more beneficial in improving exercise capacity.
在稳定型心绞痛的治疗中,比较了维拉帕米每日三次、每次120毫克与普萘洛尔每日两次、每次160毫克的疗效。在一项随机、双盲、交叉试验中,对19名患者进行了研究,采用患者日记、运动试验和动态心电图监测。两种药物均给药1个月。平均而言,维拉帕米和普萘洛尔使心绞痛发作次数同等减少。心肌缺血的心电图证据程度降低相同,但维拉帕米在延长运动时间方面明显更有效。在9名患者中进行分析的动态心电图监测24小时期间,两种药物均减少了ST段压低发作次数。得出的结论是,在稳定型心绞痛的治疗中,维拉帕米与普萘洛尔相比效果非常好,并且在改善运动能力方面更有益。